From a consumer perspective, ethical issues arising from the COVID-19 pandemic have attracted wide interest among our constituents.
CHF and consumer representatives from around the country recently participated in a workshop with the NHMRC Australian Ethics Committee and others to discuss these matters, ensuring that consumer concerns and issues were highlighted.
To inform our position on ongoing discussions on this topic, we consulted our members and networks. We received detailed responses from a broad spectrum of organisations including those involved in cancer care, disease-specific groups, rare disease patient organisations, leading mental health organisations and CHF members with interests and expertise in quality and safety, as well as a consolidated submission from the state-based peak organisations.
We are collating the extensive feedback and will release a CHF Position Statement soon.